Dr. Larry Neil Silverman, MD

Dr. Silverman practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Silverman's NPI, 1215922315, was assigned on September 14, 2005. Dr. Silverman graduated from University of Miami, Miller School of Medicine in 1993. Dr. Silverman holds Florida license ME0072235.

Dr. Silverman's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Silverman's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Silverman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silverman practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Silverman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Silverman is board certified in radiation oncology by the American Board of Radiology. Dr. Silverman is licensed in Florida.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI and colorectal cancer radiation among the conditions Dr. Silverman treats.

CMS data shows 1,605 Medicare services from Dr. Silverman across 18 procedure codes in 2024, for 302 Medicare patients. Medicare paid $159,796 for them.

CMS counts 302 Medicare patients who saw Dr. Silverman in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silverman's median patient age at 72, with 43% women.

In 2024, Dr. Silverman wrote 57 Medicare Part D claims for 42 patients. 93% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $142 in total drug cost. In 2023, CMS named 91 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Silverman for performance year 2024, reported individually. Dr. Silverman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silverman as offering telehealth.

Dmand AI links 4 papers to Dr. Silverman, published from 2011 to 2014. Dr. Silverman's most frequent co-authors are Lawrence Bruce Berk, MD, Eric Cheng Kun Chang, MD and Laurence J. Dinardo, FACS, MD.

CMS Open Payments shows 34 general payments to Dr. Silverman from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 56% of the total. Brainlab, Inc. paid the most, $1,718.

Dmand AI lists 2 awards for Dr. Silverman, most recently CMS Stage 1 EHR in 2014.

Dr. Silverman graduated from University of Miami, Miller School of Medicine in 1993.

Dr. Silverman is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.